Ganeden Biotech Inc. Harvard Case Solution & Analysis

Director General of Ganeden Biotech, a small company with a few viable probiotic products, but limited resources, must decide which markets to invest in that and strategies for intellectual property would best serve their immediate and long-term business interests.
To enhance their effectiveness, color cases should be printed in color. "Hide
by Robert C. Pozen, Dale Winger, Matthew Ahlers Source: Harvard Business School 29 pages. Publication Date: January 16, 2010. Prod. #: 310073-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.